Skip to main content

Advertisement

SpringerLink
Log in

In vivo amyloid imaging in Alzheimer’s disease

  • Diagnostic Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Abstract

Targeted approaches to therapy for Alzheimer’s disease have evolved based on detailed understanding of the genetic, molecular biologic, and neuropathologic basis of the disease. Given the potential for greater treatment efficacy in the earlier stages of the disease, the notion of early diagnosis has become more relevant. Current clinical and imaging diagnostic approaches lack reliability in the preclinical and prodromal phases of the disease. We review emerging studies on imaging of the molecular substrate of the disease, most notably the amyloid peptide, which hope to increase early diagnostic efficacy. We offer a brief overview of the demographics, diagnostic criteria, and current imaging tests, followed by a review of amyloid biology and developments in cerebral amyloid imaging yielded by recent in vitro, in vivo and human studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4a–f.
Fig. 5A, B.
Fig. 6A–C.
Fig. 7.
Fig. 8a–f.
Fig. 9A, B.
Fig. 10.
Fig. 11a, b.
Fig. 12a, b.
Fig. 13.

Similar content being viewed by others

References

  1. Rice DP, Fillit HM, Max W, Knopman DS, Lloyd JR, Duttagupta S (2001) Prevalence, costs, and treatment of Alzheimer’s disease and related dementia: a managed care perspective. Am J Manag Care 7: 809–818

    CAS  PubMed  Google Scholar 

  2. Murphy SL (2000) Deaths: final data for 1998. National Vital Statistics Report 48(11): 1–105.

    CAS  Google Scholar 

  3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34: 939–944

    PubMed  Google Scholar 

  4. American Psychological Association (1994) Diagnostic and statistical manual of mental disorders, 4 th edn. American Psychiatric Association, Washington DC

  5. Knopman DS, DeKosky ST, Cummings JL, et al (2001) Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 56: 1143–1153

    CAS  PubMed  Google Scholar 

  6. Mirra SS, Heyman A, McKeel D, et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41: 479–486

    CAS  PubMed  Google Scholar 

  7. Dickson DW (1997) Neuropathological diagnosis of Alzheimer’s disease: a perspective from longitudinal clinicopathological studies. Neurobiol Aging 18 [Suppl]: S21–S26

    Google Scholar 

  8. Anon (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s Disease. Neurobiol Aging 18 [Suppl]: S1–S2

  9. Silverman DH, Small GW, Chang CY, et al (2001) Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA 286: 2120–2127

    Article  CAS  PubMed  Google Scholar 

  10. Naslund J, Haroutunian V, Mohs R, et al (2000) Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283: 1571–1577

    Article  CAS  PubMed  Google Scholar 

  11. Selkoe DJ (2000) The origins of Alzheimer disease: a is for amyloid. JAMA 283: 1615–1617

    Article  CAS  PubMed  Google Scholar 

  12. Gowing E, Roher AE, Woods AS, et al (1994) Chemical characterization of A beta 17–42 peptide, a component of diffuse amyloid deposits of Alzheimer disease. J Biol Chem 269: 10987–10990

    CAS  PubMed  Google Scholar 

  13. Roher AE, Lowenson JD, Clarke S, et al (1993) Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer’s disease. J Biol Chem 268: 3072–3083

    CAS  PubMed  Google Scholar 

  14. Hardy J, Duff K, Hardy KG, Perez-Tur J, Hutton M (1998) Genetic dissection of Alzheimer’s disease and related dementias: amyloid and its relationship to tau. Nat Neurosci 1: 355–358

    CAS  PubMed  Google Scholar 

  15. Citron M (2000) Secretases as targets for the treatment of Alzheimer’s disease Mol Med Today 6: 392

    Google Scholar 

  16. Serpell LC (2000) Alzheimer’s amyloid fibrils: structure and assembly. Biochim Biophys Acta 1502: 16–30

    CAS  PubMed  Google Scholar 

  17. Cruz L, Urbanc B, Buldyrev SV, et al (1997) Aggregation and disaggregation of senile plaques in Alzheimer disease. Proc Natl Acad Sci USA 94: 7612–7616

    Article  CAS  PubMed  Google Scholar 

  18. Vickers JC, Dickson TC, Adlard PA, Saunders HL, King CE, McCormack G (2000) The cause of neuronal degeneration in Alzheimer’s disease. Prog Neurobiol 60: 139–165

    CAS  PubMed  Google Scholar 

  19. Pardridge WM (1998) CNS drug design based on principles of blood-brain barrier transport. J Neurochem 70: 1781–1792

    CAS  PubMed  Google Scholar 

  20. Ashburn TT, Han H, McGuinness BF, Lansbury PT Jr (1996) Amyloid probes based on Congo red distinguish between fibrils comprising different peptides. Chem Biol 3: 351–358

    Article  CAS  PubMed  Google Scholar 

  21. Klunk WE, Jacob RF, Mason RP (1999) Quantifying amyloid beta-peptide (abeta) aggregation using the Congo red-abeta (CR-abeta) spectrophotometric assay. Anal Biochem 266: 66–76

    Article  CAS  PubMed  Google Scholar 

  22. Klunk WE, Debnath ML, Pettegrew JW (1994) Development of small molecule probes for the beta-amyloid protein of Alzheimer’s disease. Neurobiol Aging 15: 691–698

    Article  CAS  PubMed  Google Scholar 

  23. Klunk WE, Debnath ML, Pettegrew JW (1995) Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe. Neurobiol Aging 16: 541–548

    Article  CAS  PubMed  Google Scholar 

  24. Dezutter NA, Dom RJ, de Groot TJ, Bormans GM, Verbruggen AM (1999) 99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer’s disease. Eur J Nucl Med 26: 1392–1399

    Article  CAS  PubMed  Google Scholar 

  25. Zhen W, Han H, Anguiano M, Lemere CA, Cho CG, Lansbury PT Jr (1999) Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer’s disease brain. J Med Chem 42: 2805–2815

    Article  CAS  PubMed  Google Scholar 

  26. Styren SD, Hamilton RL, Styren GC, Klunk WE (2000) X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer’s disease pathology. J Histochem Cytochem 48: 1223–1232

    CAS  PubMed  Google Scholar 

  27. Skovronsky DM, Zhang B, Kung MP, Kung HF, Trojanowski JQ, Lee VM (2000) In vivo detection of amyloid plaques in a mouse model of Alzheimer’s disease. Proc Natl Acad Sci USA 97: 7609–7614

    Article  CAS  PubMed  Google Scholar 

  28. Zhuang ZP, Kung MP, Hou C, et al (2001) Radioiodinated styrylbenzenes and thioflavins as probes for amyloid aggregates. J Med Chem 44: 1905–1914

    Article  CAS  PubMed  Google Scholar 

  29. Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Mathis CA (2001) Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci 69: 1471–1484

    Article  CAS  PubMed  Google Scholar 

  30. Zhuang ZP, Kung MP, Hou C, et al (2001) IBOX(2-(4’-dimethylaminophenyl)-6-iodobenzoxazole): a ligand for imaging amyloid plaques in the brain. Nucl Med Biol 28: 887–894

    Article  CAS  PubMed  Google Scholar 

  31. Majocha RE, Reno JM, Friedland RP, VanHaight C, Lyle LR, Marotta CA (1992) Development of a monoclonal antibody specific for beta/A4 amyloid in Alzheimer’s disease brain for application to in vivo imaging of amyloid angiopathy. J Nucl Med 33: 2184–2189

    CAS  PubMed  Google Scholar 

  32. Friedland RP, Shi J, Lamanna JC, Smith MA, Perry G (2000) Prospects for noninvasive imaging of brain amyloid beta in Alzheimer’s disease. Ann NY Acad Sci 903: 123–128

    CAS  PubMed  Google Scholar 

  33. Friedland RP, Kalaria R, Berridge M, et al (1997) Neuroimaging of vessel amyloid in Alzheimer’s disease. Ann NY Acad Sci 826: 242–247

    CAS  PubMed  Google Scholar 

  34. Friedland RP, Majocha RE, Reno JM, Lyle LR, Marotta CA (1994) Development of an anti-A beta monoclonal antibody for in vivo imaging of amyloid angiopathy in Alzheimer’s disease. Mol Neurobiol 9: 107–113

    CAS  PubMed  Google Scholar 

  35. Lovat LB, O’Brien AA, Armstrong SF, et al (1998) Scintigraphy with 123I-serum amyloid P component in Alzheimer disease. Alzheimer Dis Assoc Disord 12: 208–210

    CAS  PubMed  Google Scholar 

  36. Pepys MB, Rademacher TW, Amatayakul-Chantler S, et al (1994) Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure. Proc Natl Acad Sci USA 91: 5602–5606

    CAS  PubMed  Google Scholar 

  37. Hawkins PN, Rossor MN, Gallimore JR, Miller B, Moore EG, Pepys MB (1994) Concentration of serum amyloid P component in the CSF as a possible marker of cerebral amyloid deposits in Alzheimer’s disease. Biochem Biophys Res Commun 201: 722–726

    Article  CAS  PubMed  Google Scholar 

  38. Hawkins PN, Tyrell P, Jones T, et al (1991) Metabolic and scintigraphic studies with radiolabeled serum amyloid P component in amyloidosis: applications to cerebral deposits and Alzheimer disease with positron emission tomography. Bull Clin Neurosci 56: 178–190

    Google Scholar 

  39. Maggio JE, Stimson ER, Ghilardi JR, et al (1992) Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89: 5462–5466

    CAS  PubMed  Google Scholar 

  40. Saito Y, Buciak J, Yang J, Pardridge WM (1995) Vector-mediated delivery of 125I-labeled beta-amyloid peptide A beta 1–40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the A beta 1–40/vector complex. Proc Natl Acad Sci USA 92: 10227–10231

    CAS  PubMed  Google Scholar 

  41. Agdeppa ED, Kepe V, Liu J, et al (2001) Binding characteristics of radiofluorinated 6-dialkylamino-2-naphthylethylidene derivatives as positron emission tomography imaging probes for beta-amyloid plaques in Alzheimer’s disease. J Neurosci 21: RC189

    CAS  PubMed  Google Scholar 

  42. Barrio JR, Huang SC, Cole G, et al (1999) PET imaging of tangels and plaques in Alzheimer disease with a highly hydrophobic probe. J Label Comp Pharm 42: S194–S195

    Google Scholar 

  43. Shoghi-Jadid K, Small GW, Agdeppa ED, et al (2002) Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. Am J Geriatr Psychiatry 10: 24–35

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Dr Linda Gray-Leithe for her assistance in reviewing this manuscript.

Author information

Authors and Affiliations

  1. Department of Radiology, Box 3808, Duke University Medical Center, Durham, NC 27710, USA

    H. I. Sair, P. M. Doraiswamy & J. R. Petrella

Authors
  1. H. I. Sair
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. M. Doraiswamy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. R. Petrella
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. R. Petrella.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sair, H.I., Doraiswamy, P.M. & Petrella, J.R. In vivo amyloid imaging in Alzheimer’s disease. Neuroradiology 46, 93–104 (2004). https://doi.org/10.1007/s00234-003-1034-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00234-003-1034-9

Keywords

Search

Navigation